Jie Yu

2.6k total citations
96 papers, 2.0k citations indexed

About

Jie Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Materials Chemistry. According to data from OpenAlex, Jie Yu has authored 96 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Pulmonary and Respiratory Medicine and 15 papers in Materials Chemistry. Recurrent topics in Jie Yu's work include Nanoplatforms for cancer theranostics (6 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Enhanced Oil Recovery Techniques (6 papers). Jie Yu is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Enhanced Oil Recovery Techniques (6 papers). Jie Yu collaborates with scholars based in China, United States and Macao. Jie Yu's co-authors include Michael S. Wong, Mohammad A. Yaseen, Bahman Anvari, Xiuping Chen, Jin‐Jian Lu, Ying Hou, Rebecca Richards‐Kortum, David Javier, Nitin Nitin and Mason B. Tomson and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Energy & Environmental Science.

In The Last Decade

Jie Yu

87 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Yu China 24 660 599 336 332 316 96 2.0k
Haotian Yang China 13 535 0.8× 407 0.7× 144 0.4× 167 0.5× 208 0.7× 42 1.4k
Xiaoxi Yang China 36 737 1.1× 720 1.2× 206 0.6× 291 0.9× 645 2.0× 140 3.6k
Shuo Liu China 26 844 1.3× 348 0.6× 233 0.7× 79 0.2× 300 0.9× 80 2.3k
Norio Itoh Japan 28 1.0k 1.6× 372 0.6× 143 0.4× 109 0.3× 666 2.1× 97 3.5k
Naoki Utoguchi Japan 28 1.2k 1.8× 871 1.5× 381 1.1× 81 0.2× 436 1.4× 85 3.0k
Jin Li China 34 1.3k 2.0× 552 0.9× 535 1.6× 184 0.6× 248 0.8× 133 3.4k
Xueliang Liu China 31 890 1.3× 732 1.2× 243 0.7× 93 0.3× 868 2.7× 153 2.9k
Dongxia Li China 34 1.7k 2.5× 494 0.8× 448 1.3× 101 0.3× 500 1.6× 144 3.4k
Na Qi China 23 396 0.6× 378 0.6× 325 1.0× 63 0.2× 212 0.7× 108 1.8k
Guoliang Chen China 31 925 1.4× 460 0.8× 160 0.5× 90 0.3× 632 2.0× 216 3.8k

Countries citing papers authored by Jie Yu

Since Specialization
Citations

This map shows the geographic impact of Jie Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Yu more than expected).

Fields of papers citing papers by Jie Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Yu. The network helps show where Jie Yu may publish in the future.

Co-authorship network of co-authors of Jie Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Yu. A scholar is included among the top collaborators of Jie Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Yu. Jie Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gong, Dihong, et al.. (2025). Novel Parkin agonists from Poria cocos against dyslipidemia. Fitoterapia. 182. 106469–106469. 1 indexed citations
3.
Gong, Dihong, Li Duan, Wen Gu, et al.. (2025). A multidimensional perspective on Poria cocos, an ancient fungal traditional Chinese medicine. Journal of Ethnopharmacology. 348. 119869–119869. 5 indexed citations
4.
Lyu, Bin, Jie Yu, Siqi Bao, et al.. (2025). Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning. British Journal of Pharmacology. 183(2). 364–378. 1 indexed citations
5.
Hou, Ying, Bingling Zhong, Lin Zhao, et al.. (2024). A small molecule cryptotanshinone induces non-enzymatic NQO1-dependent necrosis in cancer cells through the JNK1/2/Iron/PARP/calcium pathway. Acta Pharmaceutica Sinica B. 15(2). 991–1006. 1 indexed citations
6.
Wang, Yang, Tao Liu, Chenxi Jia, et al.. (2024). A novel variant in the SPTB gene underlying hereditary spherocytosis and a literature review of previous variants. BMC Medical Genomics. 17(1). 206–206. 2 indexed citations
7.
Wang, Yang, Tao Liu, Jiaqi Liu, et al.. (2023). The novel compound heterozygous variants identified in a Chinese family with glucose phosphate isomerase deficiency and pathogenicity analysis. BMC Medical Genomics. 16(1). 162–162. 1 indexed citations
8.
Yu, Jie, Bingling Zhong, Lin Zhao, et al.. (2023). Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis. Drug Resistance Updates. 70. 100977–100977. 53 indexed citations
9.
Hou, Ying, Rong Liu, Bingling Zhong, et al.. (2021). Nannocystin ax, an eEF1A inhibitor, induces G1 cell cycle arrest and caspase-independent apoptosis through cyclin D1 downregulation in colon cancer in vivo. Pharmacological Research. 173. 105870–105870. 20 indexed citations
10.
Yu, Jie, Bingling Zhong, Lida Du, et al.. (2020). Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds. Pharmacology & Therapeutics. 214. 107593–107593. 55 indexed citations
11.
Zhao, Hailan & Jie Yu. (2019). Prevalence and Associated Factors of Myopia among Third-Grade Primary School Students in the Gongshu District of Hangzhou. Chinese Journal of Optometry & Ophthalmology. 21(5). 321–326. 3 indexed citations
12.
Liu, Shan, Haiyan Liu, Qin Ru, et al.. (2017). The cellular senescence of leukemia-initiating cells from acute lymphoblastic leukemia is postponed by β-Arrestin1 binding with P300-Sp1 to regulate hTERT transcription. Cell Death and Disease. 8(4). e2756–e2756. 25 indexed citations
13.
14.
Moorman, Anthony V., Julie Irving, Amir Enshaei, et al.. (2015). Composite Index for Risk Prediction in Relapsed Childhood Acute Lymphoblastic Leukaemia. Haematologica. 100. 195–196. 3 indexed citations
15.
Zhang, Wei, et al.. (2014). Emodin azide methyl anthraquinone derivative induced G0/ G1 arrest in HER2/neu-overexpressing MDA-MB-453 breast cancer cells.. PubMed. 19(3). 650–5. 7 indexed citations
16.
Yu, Jie, Lu Wang, Amy T. Kan, et al.. (2013). Salt- and temperature-stable quantum dot nanoparticles for porous media flow. Colloids and Surfaces A Physicochemical and Engineering Aspects. 443. 492–500. 24 indexed citations
17.
18.
Fan, Chunfang, Amy T. Kan, Ping Zhang, et al.. (2012). Scale Prediction and Inhibition for Oil and Gas Production at High Temperature/High Pressure. SPE Journal. 17(2). 379–392. 48 indexed citations
19.
Xu, Ying, Jianchun Pan, Ling Chen, et al.. (2011). Curcumin prevents corticosterone‐induced neurotoxicity and abnormalities of neuroplasticity via 5‐HT receptor pathway. Journal of Neurochemistry. 118(5). 784–795. 33 indexed citations
20.
Yu, Jie, et al.. (2009). Pressure-Induced Structural Transitions of the Zinc Sulfide Nano-particles with Different Sizes. Journal of Material Science and Technology. 23(2). 193–195. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haotian Yang Breakdown of academic impact, for papers by Xiaoxi Yang Breakdown of academic impact, for papers by Shuo Liu Breakdown of academic impact, for papers by Norio Itoh Breakdown of academic impact, for papers by Naoki Utoguchi Breakdown of academic impact, for papers by Jin Li Breakdown of academic impact, for papers by Xueliang Liu Breakdown of academic impact, for papers by Dongxia Li Breakdown of academic impact, for papers by Na Qi Breakdown of academic impact, for papers by Guoliang Chen
Rankless by CCL
2026